MedTrace Logo

Early Outcomes of Concomitant Transcatheter Aortic Valve Implantation and Off-pump Coronary Artery Bypass Grafting in Management of Severe Symptomatic Aortic Stenosis and Coronary Artery Disease

NCT04525339 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2020-08-25

No results posted yet for this study

Summary

Study Objectives/Specific Aims Overall Goal: To study the outcomes of patients undergoing TAVI, their subsequent results and complications.

* Objective 1: Identify risk factors that are predictive of the need for TAVI and CABG
* Objective3:Assess early 3 months outcomes and postoperative results

Outcome Measure:

1\. All-cause mortality within 3 months.

Secondary Outcome Measures:

1. Stroke
2. Myocardial infarction
3. Bleeding
4. Hospital stay
5. Acute kidney injury
6. Number of patients with conduction disturbance and pacemaker implantation
7. Gradient on implanted valve
8. Degree of transvalvular leakage
9. 6 weeks follow-up
10. 3 months Echo

Conditions

Interventions

PROCEDURE

TAVI and Off pump CABG

Concomitant Transcatheter aortic valve implanatation and off pump coronary artery bypass grafting

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-12-31
Completion
2021-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04525339 on ClinicalTrials.gov